Sofgen, a supplier of softgel technologies for generics, prescription drugs, OTC products and specialised nutraceuticals, ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative ...

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Procaps Group, a leading integrated international healthcare and pharmaceutical company, today announced the closing of an asset purchase agreement to acquire an 86,000ft² pharmaceutical production ...

At Softigel by Procaps, we develop complex products encapsulated in softgel dosage forms and other delivery systems, high potency APIs, differentiated OTC products and nutritional supplements in novel ...